GXE.DE · LAKEFRONT BIOTHERAPEUTICS
Germany · RS rating 59 · As of 2026-10-14
| Price | 26.14 EUR |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 86 / 57 / 34 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 22 / 40 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +86.8% |
| Distance from 52-week high | +13.0% |
| Market cap (USD) | $1.9B |